Oral iron supplementation
Pro Research Analysisby 
Searched over 200M research papers
Oral Iron Supplementation: Efficacy and Indications
Oral iron supplementation is the primary treatment for iron deficiency and iron-deficiency anemia, which are common worldwide, especially among women and pregnant individuals Pantopoulos2024Stoffel2020Lo2022+1 MORE. Ferrous sulfate is the most widely used and cost-effective oral iron salt, but other formulations, including ferric complexes and newer options like ferric maltol and sucrosomial® iron, are also available Pantopoulos2024Gómez‐Ramírez2018. Oral iron is generally effective in correcting anemia and replenishing iron stores, and is recommended as the first-line therapy in most cases Pantopoulos2024Lo2022Pasricha2020.
Dosing Strategies and Iron Absorption
Traditional guidelines have recommended daily doses of 150–200 mg elemental iron, often split throughout the day . However, recent research shows that high doses and frequent dosing can increase hepcidin, a hormone that limits iron absorption, resulting in less efficient uptake and more unabsorbed iron in the gut Stoffel2020Lo2022Moretti2015+2 MORE. Studies in iron-deficient women demonstrate that single morning doses of 60–120 mg iron, given on alternate days, maximize absorption and reduce side effects compared to daily or split dosing Stoffel2020Moretti2015Stoffel2017. Alternate-day dosing allows hepcidin levels to return to baseline, improving iron uptake Stoffel2020Moretti2015Stoffel2017.
Side Effects and Tolerability
Gastrointestinal side effects such as constipation, bloating, and dyspepsia are common with oral iron, affecting up to 50% of patients and leading to poor adherence Pantopoulos2024Gómez‐Ramírez2018Bloor2021. These side effects are linked to unabsorbed iron in the gut, which can also disrupt the gut microbiota and promote the growth of harmful bacteria Lo2022Bloor2021. Newer formulations like sucrosomial® iron have shown better gastrointestinal tolerance and similar or improved efficacy compared to traditional iron salts, making them a good option for patients who cannot tolerate standard oral iron Pantopoulos2024Gómez‐Ramírez2018.
Monitoring Response and When to Switch to IV Iron
Most patients respond to oral iron, with a significant increase in hemoglobin (≥1.0 g/dL) within 14 days indicating a good response . If there is less than a 1.0 g/dL increase in hemoglobin after two weeks, switching to intravenous iron should be considered, as continued oral therapy is unlikely to be effective . IV iron is also preferred when oral iron is contraindicated or not tolerated Pantopoulos2024Lo2022Okam2017.
Special Populations: Pregnancy and Chronic Conditions
Daily oral iron supplementation during pregnancy reduces maternal anemia and iron deficiency at term, and may lower the risk of low birthweight infants . However, evidence for other maternal and infant outcomes is less certain . In patients with chronic conditions (e.g., chronic kidney disease, cancer, bariatric surgery), sucrosomial® iron may be as effective as IV iron, with fewer risks .
Conclusion
Oral iron supplementation remains the first-line treatment for iron deficiency and iron-deficiency anemia. Recent evidence supports using single morning doses of 60–120 mg on alternate days to maximize absorption and minimize side effects. Newer formulations like sucrosomial® iron offer improved tolerability for those who cannot use traditional iron salts. Monitoring early hemoglobin response helps identify patients who may need intravenous iron. These strategies can improve treatment outcomes and patient adherence.
Sources and full results
Most relevant research papers on this topic